Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
NCT01134510
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplantation
Interventions
DRUG:
C1 Esterase Inhibitor
DRUG:
Placebos
Sponsor
Stanley Jordan, MD
Collaborators
[object Object]